Proceedings of the Society for Experimental Biology and Medicine 1997-12-01

In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.

K E Kinnamon, B T Poon, W L Hanson, V B Waits

Index: Proc. Soc. Exp. Biol. Med. 216(3) , 424-8, (1997)

Full Text: HTML

Abstract

Forty-nine "standard" compounds known to be useful in the treatment of other diseases were tested for their suppressive activity against the trypomastigotes of Trypanosoma cruzi-infected mice. The most active was the antidepressant protriptyline, which was almost three times as effective as the reference drug, nifurtimox. A major value of the present data is to demonstrate the refractoriness of the T. cruzi parasite against many of the drug standards that have known biological activity.


Related Compounds

Related Articles:

Protriptyline, chronic tension-type headaches, and weight loss in women.

1997-01-01

[Headache 37(7) , 433-6, (1997)]

Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease.

1997-01-01

[Respiration 64 Suppl 1 , 35-8, (1997)]

The carotid body in the motorneuron response to protriptyline.

1993-07-01

[Respir. Physiol. 93(1) , 41-9, (1993)]

In vitro studies of DNA damage caused by tricyclic antidepressants: a role of peroxidase in the side effects of the drugs.

2010-09-20

[Chem. Res. Toxicol. 23(9) , 1497-503, (2010)]

Hyperekplexia: report of a nonfamilial adult onset case associated with obstructive sleep apnea and abnormal brain nuclear tomography.

1994-04-01

[Sleep 17(3) , 280-3, (1994)]

More Articles...